1. Of the judgment of the court of first instance, the judgment against the Defendants in collaboration with the Defendants was 22,382,841 won, Plaintiff B, D, and C respectively. 7,878.

The reasoning for the court's explanation of this part of the premise facts is the same as that of the corresponding part of the judgment of the court of first instance, and thus, they are cited by the main text of Article 420 of the Civil Procedure

손해배상책임의 성립 책임의 근거 문진상의 과실 원고들의 주장 망인은 2011. 10. 26.경 일반건강검진시 총 콜레스테롤 수치 246mg /dL의 검사결과 및 전고혈압의 진단을 받았고, 이로 인해 협심증 및 심근경색증에 관하여 중증도의 위험이 있다는 건강검진결과에 따라 심혈관계 질환약인 카듀엣 정을 처방받아 30회 이상 복용하고 있었음에도 망인이 응급실에 방문할 당시 피고 E은 위와 같은 병력을 제대로 문진하지 않았으며, 이와 같은 피고 E의 문진상의 과실이 망인의 심근경색증을 조기에 진단하지 못하고, 망인이 사망에 이르게 하는데 기여하였다.

Judgment

According to Gap evidence Nos. 6-5, Gap evidence Nos. 13 and 16, the deceased was subject to a general health examination on October 31, 201, and was notified of the result of the examination on the general health examination. The deceased’s 246mg/dL [the normal A (Health Care) less than 200mg/dL, normalB ( border) to 239m/dL], blood pressure 127mHg/81mHg [the normal health care) less than 120mHg/80mHg/80mHg, normalB ( border) less than 120 to 139mHg/80m Hg/89mHg], the deceased’s 200 to 139mHg/80mHg, and the deceased’s 200 to 27m high-tension of the deceased’s health condition was not notified of the first prescription of the deceased’s disease.”